{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T05:37:03Z","timestamp":1671687423403},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00393-020-00927-8","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T12:03:22Z","timestamp":1606824202000},"page":"29-42","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rehabilitation seltener Erkrankungen im Erwachsenenalter: Osteogenesis imperfecta"],"prefix":"10.1007","volume":"80","author":[{"given":"M.","family":"Gehlen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schwarz-Eywill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Siebers-Renelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ratanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"927_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00112-016-0189-5","volume":"165","author":"H Hoyer-Kuhn","year":"2017","unstructured":"Hoyer-Kuhn\u00a0H, Bartz-Seel\u00a0J, Blickheuser\u00a0R, Deimling\u00a0U, St\u00fccker\u00a0R, Wirth\u00a0T, Wolf\u00a0J, Wollinsky\u00a0KH, Semler\u00a0O (2017) Diagnostik und Therapie der Osteogenesis imperfecta. Monatsschr Kinderheilkd 165:333\u2013346","journal-title":"Monatsschr Kinderheilkd"},{"key":"927_CR2","first-page":"w14322","volume":"146","author":"A Bourgeoisa","year":"2016","unstructured":"Bourgeoisa\u00a0A, Aubry-Rozierb\u00a0B, Bonaf\u00e9c\u00a0L, Applegated\u00a0L, Piolettie\u00a0D, Zambellia\u00a0P (2016) Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives. Swiss Med Wkly 146:w14322","journal-title":"Swiss Med Wkly"},{"issue":"12","key":"927_CR3","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","volume":"27","author":"P Trejo","year":"2016","unstructured":"Trejo\u00a0P, Rauch\u00a0F (2016) Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int 27(12):3427\u20133437 (Dec)","journal-title":"Osteoporos Int"},{"issue":"12","key":"927_CR4","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/ajmg.a.61366","volume":"179","author":"G Mortier","year":"2019","unstructured":"Mortier\u00a0G, Cohn\u00a0D, Cormier-Daire\u00a0V, Hall\u00a0C, Krakow\u00a0D, Mundlos\u00a0S, Nishimura\u00a0G, Robertson\u00a0S, Sangiorgi\u00a0L, Savarirayan\u00a0R, Sillence\u00a0D, Superti-Furga\u00a0A, Unger\u00a0S, Warman\u00a0M (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet\u00a0A 179(12):2393\u20132419","journal-title":"Am J Med Genet A"},{"issue":"8","key":"927_CR5","doi-asserted-by":"publisher","first-page":"e10174","DOI":"10.1002\/jbm4.10174","volume":"3","author":"J Tauer","year":"2019","unstructured":"Tauer\u00a0J, Robinson\u00a0M\u2011E, Rauch\u00a0F (2019) Osteogenesis imperfecta: new perspectives from clinical and translational research. Jbmr Plus 3(8):e10174","journal-title":"Jbmr Plus"},{"key":"927_CR6","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini\u00a0JC, Forlino\u00a0A, B\u00e4chinger\u00a0HP, Bishop\u00a0NJ, Byers\u00a0PH, Paepe\u00a0A, Fassier\u00a0F, Fratzl-Zelman\u00a0N, Kozloff\u00a0KM, Krakow\u00a0D, Montpetit\u00a0K, Semler\u00a0O (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"927_CR7","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/ajmg.a.37365","volume":"167A","author":"L Bonafe","year":"2015","unstructured":"Bonafe\u00a0L, Cormier-Daire\u00a0V, Hall\u00a0C, Lachman\u00a0R, Mortier\u00a0G, Mundlos\u00a0S, Nishimura\u00a0G, Sangiorgi\u00a0L, Savarirayan\u00a0R, Sillence\u00a0D, Spranger\u00a0J, Superti-Furga\u00a0A, Warman\u00a0M, Unger\u00a0S (2015) Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet\u00a0A 167A(12):2869\u20132892","journal-title":"Am J Med Genet A"},{"key":"927_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00393-019-0671-2","volume":"78","author":"C Hofmann","year":"2019","unstructured":"Hofmann\u00a0C, Girschick\u00a0H, Lapa\u00a0C, Semler\u00a0O, Jakob\u00a0F (2019) Fractures and bone mineral density in childhood. Z Rheumatol 78:636\u2013644","journal-title":"Z. Rheumatol."},{"key":"927_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11657-011-0054-z","volume":"6","author":"L Wekre","year":"2011","unstructured":"Wekre\u00a0L, Eriksen\u00a0E, Falch\u00a0J (2011) Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta. Arch Osteoporos 6:31\u201333","journal-title":"Arch Osteoporos"},{"key":"927_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13023-018-0905-4","volume":"13","author":"B Mueller","year":"2018","unstructured":"Mueller\u00a0B, Engelbert\u00a0R, Baratta-Ziska\u00a0F, Bartels\u00a0B, Blanc\u00a0N, Brizola\u00a0E, Fraschini\u00a0P, Hill\u00a0C, Marr\u00a0C, Mills\u00a0L, Montpetit\u00a0K, Pacey\u00a0V, Rodriguez Molina\u00a0M, Schuuring\u00a0M, Verhille\u00a0C, de Vries\u00a0O, Hiu Kwong Yeung\u00a0E, Semler\u00a0O (2018) Consensus statement on physical rehabilitation in children and adolescents with osteogenesis imperfecta. Orphanet J Rare Dis 13:158","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"927_CR11","first-page":"1","volume":"17","author":"L Veilleu","year":"2017","unstructured":"Veilleu\u00a0L, Trejo\u00a0P, Rauch\u00a0F (2017) Muscle abnormalities in osteogenesis imperfecta. J\u00a0Musculoskelet Neuronal Interact 17(2):1\u20137","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"927_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-0038-1676922","volume":"27","author":"O Semler","year":"2018","unstructured":"Semler\u00a0O, Rehberg\u00a0M, Hoyer-Kuhn\u00a0H (2018) Pathophysiology ad treatment of osteogenesis imperfecta. Osteologie 27:194\u2013199","journal-title":"Osteologie"},{"key":"927_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-12-54","volume":"12","author":"C Hill","year":"2014","unstructured":"Hill\u00a0C, Baird\u00a0W, Walters\u00a0S (2014) Quality of life in children and adolescents with osteogenesis Imperfecta: a\u00a0qualitative interview based study. Health Qual Life Outcomes 12:54","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"927_CR14","first-page":"445","volume":"14","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn\u00a0H, Semler\u00a0O, Stark\u00a0C, Struebing\u00a0N, Goebel\u00a0O, Schoenau\u00a0E (2014) A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J\u00a0Musculoskelet Neuronal Interact 14(4):445\u2013453","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"8","key":"927_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00393-018-0510-x","volume":"77","author":"M Tiefenbach","year":"2018","unstructured":"Tiefenbach\u00a0M, Scheel\u00a0M, Maier\u00a0A, Gehlen\u00a0M, Schwarz-Eywill\u00a0M, Werner\u00a0M, Siebers-Renelt\u00a0U, Hammer\u00a0M (2018) Osteomalacia-Clinical aspects, diagnostics and treatment. Z\u00a0Rheumatol 77(8):703\u2013718","journal-title":"Z Rheumatol"},{"issue":"1","key":"927_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s15014-013-0021-9","volume":"25","author":"H Hoyer-Kuhn","year":"2013","unstructured":"Hoyer-Kuhn\u00a0H, Semler\u00a0O (2013) Die Glasknochenkrankheit wird immer komplexer. Osteogenesis imperfecta: Neues zur Pathogenese und Therapie. p\u00e4diatr hautnah 25(1):28\u201332","journal-title":"p\u00e4diatr hautnah"},{"issue":"2","key":"927_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5582\/irdr.2019.01064","volume":"8","author":"Y Lu","year":"2019","unstructured":"Lu\u00a0Y, Zhang\u00a0S, Wang\u00a0Y, Ren\u00a0X, Han\u00a0J (2019) Molecular mechanisms and clinical manifestations of rare genetic disorders associated with type I collagen. Intractable Rare Dis Res 8(2):98\u2013107","journal-title":"Intractable Rare Dis Res"},{"issue":"10","key":"927_CR18","first-page":"CD005088","volume":"10","author":"K Dwan","year":"2016","unstructured":"Dwan\u00a0K, Phillipi\u00a0C, Steiner\u00a0R, Basel\u00a0D (2016) Bisphosphonate therapy for osteogenesis Imperfecta. Cochrane Database Syst Rev 10(10):CD5088","journal-title":"Cochrane Database Syst Rev"},{"key":"927_CR19","unstructured":"Steiner\u00a0R, Basel\u00a0D (2019) COL1A1\/2 Osteogenesis Imperfecta. Genereviews\u00ae [internet]. Seattle (WA): University of Washington, Seattle. PMID: 2030147"},{"issue":"2","key":"927_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11138\/ccmbm\/2017.14.1.153","volume":"14","author":"P Tranquilli Leali","year":"2017","unstructured":"Tranquilli Leali\u00a0P, Balsano\u00a0M, Maestretti\u00a0G, Brusoni\u00a0M, Amorese\u00a0V, Ciurlia\u00a0E, Andreozzi\u00a0M, Caggiari\u00a0G, Doria\u00a0C (2017) Efficacy of Teriparatide vs Neridronate in adults with osteogenesis imperfecta type\u00a0I: a\u00a0prospective randomized international clinical study. Clin Cases Miner Bone Metab 14(2):153\u2013156","journal-title":"Clin Cases Miner Bone Metab"},{"key":"927_CR21","first-page":"2002","volume":"28","author":"M Gehlen","year":"2019","unstructured":"Gehlen\u00a0M, Pfeifer\u00a0M, Lazarescu\u00a0AD et\u00a0al (2019) The law of severely disabled persons and its assessment of patients with osteoporosis. Osteologie 28:2002\u20132009","journal-title":"Osteologie"},{"issue":"5","key":"927_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00393-013-1342-3","volume":"73","author":"W Bureck","year":"2014","unstructured":"Bureck\u00a0W, Illgner\u00a0U (2014) Hand ergotherapy for rheumatic diseases and the special importance of hand surgery. Z\u00a0Rheumatol 73(5):424","journal-title":"Z Rheumatol"},{"key":"927_CR23","volume-title":"Kursbuch Sozialmedizin","author":"R Diehl","year":"2014","unstructured":"Diehl\u00a0R, Gebauer\u00a0E, Groner\u00a0A (2014) Kursbuch Sozialmedizin. Deutscher \u00c4rzteverlag, K\u00f6ln"},{"issue":"6","key":"927_CR24","first-page":"613","volume":"50","author":"K Kroenke","year":"2009","unstructured":"Kroenke\u00a0K, Spitzer\u00a0RL, Williams\u00a0JB et al (2009) An ultra-brief screening scale for anxiety and depression: the PHQ\u20114. Psychosomatics 50(6):613\u2013621","journal-title":"Psychosomatics"},{"key":"927_CR25","first-page":"2010","volume":"28","author":"M Gehlen","year":"2019","unstructured":"Gehlen\u00a0M, Pfeifer\u00a0M, Lazarescu\u00a0AD et al (2019) Socio-medical assessment of patients suffering from osteoporosis. Osteologie 28:2010\u20132017","journal-title":"Osteologie"},{"key":"927_CR26","unstructured":"Programm f\u00fcr Nationale Versorgungs Leitlinien. Nationale Versorgungs Leitlinie Nicht-spezifischer Kreuzschmerz. 2.\u00a0Auflage, 2017 Version 1"},{"key":"927_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-2007-963494","volume":"32","author":"U Lange","year":"2007","unstructured":"Lange\u00a0U, Uhlemann\u00a0C, Berg\u00a0W et\u00a0al (2007) Physical medicine in rheumatology\u2014differential indicative prescription in collagen diseases and vasculitides. Akt Rheumatol 32:281\u2013286","journal-title":"Akt Rheumatol"},{"issue":"10","key":"927_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00393-017-0404-3","volume":"76","author":"M Pfeifer","year":"2017","unstructured":"Pfeifer\u00a0M, Gehlen\u00a0M, Hinz\u00a0C (2017) Spinal orthoses in the treatment of vertebral fractures with osteoporosis. A systematic review article. Z\u00a0Rheumatol 76(10):860\u2013868","journal-title":"Z Rheumatol"},{"key":"927_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00393-018-0511-9","volume":"77","author":"A Klein","year":"2018","unstructured":"Klein\u00a0A, Olbert\u00a0F, Wintrich\u00a0S, Lutz-Wiegers\u00a0V, Horneff\u00a0G (2018) Transition in pediatric rheumatology-expeiences from the pediatric rheumatism center Stank Augustin. Z Rheumatol 77:677\u2013684","journal-title":"Z. Rheumatol."}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-020-00927-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00927-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T03:59:17Z","timestamp":1612929557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-020-00927-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00927-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"1 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.\u00a0Gehlen<\/b>: Finanzielle Interessen: Referentenhonorare f\u00fcr Sonographiekurse: Bristol-Myers Squibb, AbbVie Deutschland, Novartis. Nichtfinanzielle Interessen: Chefarzt, Klinik DER F\u00dcRSTENHOF, Bad Pyrmont | Mitgliedschaften: DGRh, DEGUM, DEGIM, Rheumaliga Niedersachsen (Vorstand), DVMB Niedersachsen (beratender Arzt). <b>M.\u00a0Schwarz-Eywill<\/b>: Finanzielle Interessen: Teilerstattung der Geb\u00fchr f\u00fcr 3\u00a0Ultraschallkurse: Fa. Novartis. Nichtfinanzielle Interessen: Angestellter Facharzt f\u00fcr Rheumatologie, Klinik DER F\u00dcRSTENHOF, Bad Pyrmont | Mitgliedschaft: DGRh. <b>C.\u00a0Hinz<\/b>: Finanzielle Interessen: Teilerstattung der Geb\u00fchr eines Ultraschallkurses: Fa. Novartis. Nichtfinanzielle Interessen: Chefarzt der Orthop\u00e4die, Klinik DER F\u00dcRSTENHOF, Bad Pyrmont. <b>M.\u00a0Pfeifer<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Osteologe, Institut f\u00fcr klinische Osteologie, Klinik DER F\u00dcRSTENHOF, Bad Pyrmont, Osteologisches Forschungsinstitut Gustav Pommer e.\u202fV. | Mitgliedschaften: DVO, Leitlinienkommission Osteoporose 2017 (Vorsitzender). <b>U.\u00a0Siebers-Renelt<\/b>: Finanzielle Interessen: Referentenhonorar im Rahmen der curricularen Fortbildung \u201eOsteologie\u201c der OSTAC. Nichtfinanzielle Interessen: Ober\u00e4rztin, Institut f\u00fcr Humangenetik, Universit\u00e4tsklinik M\u00fcnster | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Humangenetik (GfH), Europ\u00e4ische Gesellschaft f\u00fcr Humangenetik (ESHG), Konsortium Famili\u00e4rer Brust- und Eierstockkrebs (komm. Zentrumssprecherin), Konsortium Famili\u00e4rer Darmkrebs (Zentrumssprecherin). <b>M.\u00a0Ratanski<\/b>: Finanzielle Interessen: Jeweils bezahlte Teilnahmegeb\u00fchr an Fortbildungen: Medac, Pfizer, UCB, Lilly, AbbVie, Bristol-Myers Squibb. \u2013 Tutorin: Ultraschallkurs Arthrosonographie Bristol-Myers Squibb. Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin, Rheumatologin, Abteilung f\u00fcr Rheumatologie, CA Prof. Hammer, St. Josef-Stift Sendenhorst, Zusatzbezeichnung Osteologin DVO | Einfache Mitgliedschaften: Gesellschaft f\u00fcr Osteologie, Gesellschaft f\u00fcr Rheumatologie. <b>A.\u00a0Maier<\/b>: Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie, BMS, Chugai\/Roche, Janssen, Medac, MSD, Novartis, Pfizer, UCB. Nichtfinanzielle Interessen: Ober\u00e4rztin, Klinik f\u00fcr Rheumatologie, St. Josef-Stift Sendenhorst, Rheumatologisches Kompetenzzentrum Nordwestdeutschland | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie (DGRh), Deutsche Gesellschaft f\u00fcr Ultraschall in der Medizin (DEGUM).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}